# Ovarian Aging in Low Grade Glioma (LGG) Treated With Temozolomide

> **NCT01452854** · — · TERMINATED · sponsor: **University of California, San Francisco** · enrollment: 2 (actual)

## Conditions studied

- Low Grade Glioma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01452854
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2011-10
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Low recruitment, sponsor withdrew funding.
- **Last updated:** 2022-07-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01452854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01452854, "Ovarian Aging in Low Grade Glioma (LGG) Treated With Temozolomide". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01452854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*